<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-58LEK9Q9</identifier><date>2016</date><creator>Zidar, Janez</creator><relation>documents/doc/5/URN_NBN_SI_doc-58LEK9Q9_001.pdf</relation><relation>documents/doc/5/URN_NBN_SI_doc-58LEK9Q9_001.txt</relation><format format_type="issue">2/3</format><format format_type="volume">67</format><format format_type="type">article</format><format format_type="extent">str. 179-185</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2997420</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-58LEK9Q9</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">klinične značilnosti</subject><subject language_type_id="slv">mišična distrofija</subject><subject language_type_id="slv">razvrščanje</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Mišične distrofije</title><title>Muscular dystrophies</title></Record>